Edwards Lifesciences Corp. will pay $10 million in civil penalties to resolve claims that it intentionally evaded antitrust review of its 2024 purchase of medical device maker JC Medical.
Edwards is a California-based medical device firm that develops and supplies products such as transcatheter heart valves and pressure transducers for the healthcare industry.